How AI Is Changing IT Operations in Biotech — A Practitioner's Perspective
There's a lot of noise about AI transforming every industry, and most of it is abstract — impressive demos, theoretical use cases, and conference talks about the future of work. What's harder to find is a straightforward account of how AI actually changes the day-to-day work of an IT leader at a real company.
I can offer that perspective. Over the past year, I've integrated AI tools into nearly every aspect of my work as an IT Director at a pharmaceutical company. Not as an experiment — as a core part of how I deliver results. Here's what that looks like in practice, and what it means for IT operations in biotech and pharma.
Where AI Actually Adds Value in IT Operations
The biggest misconception about AI in IT is that it's about chatbots and help desk automation. Those applications exist, but they're not where the real leverage is for a small IT team.
The real value is in three areas: accelerated software development, documentation and knowledge management, and decision support for architecture and security.
Building Production Applications in Weeks
The most transformative change in my own work has been using AI-assisted development to build custom internal applications. Using tools like Claude and Claude Code, I've designed and deployed production applications on Microsoft Azure that would have previously required a dedicated development team and months of timeline.
These aren't prototypes or demos. They're production systems handling real business processes — a regulatory compliance monitoring dashboard tracking shared mailbox response times, an internal recruiting and application portal replacing manual email workflows, and a custom HRIS system designed to replace a costly third-party platform.
The AI doesn't write the code and walk away. The workflow is collaborative: I define the architecture and business requirements, the AI generates implementation code, I review and refine, and together we iterate to a production-ready solution. The result is a dramatically compressed timeline — what used to take a team of developers three to six months, I can deliver in weeks.
Documentation and Knowledge Management
Every IT leader knows that documentation is both essential and perpetually behind. AI has fundamentally changed this equation. I use AI tools to draft technical documentation, create runbooks, generate process flows from verbal descriptions, and maintain up-to-date knowledge bases.
For a solo IT operation, this is game-changing. Documentation that would take hours to write from scratch takes minutes to generate and refine. The quality is consistent, the formatting is professional, and the knowledge actually gets captured instead of living in someone's head.
Architecture and Security Decision Support
When you're the sole IT person at a company, every architecture decision rests on your shoulders. AI provides what I'd describe as an always-available senior peer reviewer. Before implementing a new Entra ID conditional access policy or configuring an Okta integration, I can describe the environment and requirements and get back a thoughtful analysis of considerations I might have missed.
This isn't about outsourcing decisions to AI — it's about having a sounding board that's available at 10pm when you're configuring something that can't wait for Monday.
What This Means for Biotech IT Teams
The practical implication for biotech and pharma IT is significant: small teams can now deliver outcomes that previously required much larger departments or expensive consulting engagements.
A company with 50-200 employees and a single IT Director can now build custom internal tools, maintain comprehensive documentation, and make well-informed architecture decisions — all at a pace that matches the urgency of a startup environment.
This doesn't mean AI replaces IT professionals. If anything, it raises the bar for what a skilled IT leader can deliver, which makes the human even more valuable — you need someone who understands the business context, the compliance requirements, and the architecture decisions well enough to direct the AI effectively.
Getting Started Practically
If you're an IT leader in biotech looking to integrate AI into your operations, start with these three steps:
First, identify your biggest time sink. For most small IT teams, it's documentation, repetitive configuration tasks, or building tools that don't exist off-the-shelf. That's where AI will give you the most immediate return.
Second, pick one tool and go deep. Don't spread across five AI platforms. Choose one — I recommend Claude for technical work — and learn its capabilities thoroughly. The quality of your results depends on how well you can articulate requirements and architecture decisions to the AI.
Third, start with internal tools, not customer-facing applications. The compliance bar for internal productivity tools is much lower than for anything touching patient data or regulatory submissions. Build confidence and demonstrate value internally before expanding scope.
The Bottom Line
AI isn't replacing IT teams in biotech — it's amplifying them. An IT Director who knows how to leverage these tools effectively can deliver outcomes that simply weren't possible for a single person two years ago. For companies that need enterprise-grade IT outcomes on a startup budget, that's a meaningful shift.